scispace - formally typeset
F

Franco Borzio

Researcher at University of Milan

Publications -  68
Citations -  4744

Franco Borzio is an academic researcher from University of Milan. The author has contributed to research in topics: Hepatocellular carcinoma & Liver cancer. The author has an hindex of 36, co-authored 68 publications receiving 4084 citations.

Papers
More filters
Journal ArticleDOI

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

TL;DR: Cirrhotic patients infected with HCV type 1b carry a significantly higher risk of developing HCC than patients infected by other HCV types, and the latter may require a less intensive clinical surveillance for the early detection of neoplasia.
Journal ArticleDOI

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

TL;DR: The evaluation of this large series of HCC patients allowed us to confirm the low sensitivity of AFP in the diagnosis of H CC and its prognostic value, albeit limited, being tumor size, female sex, Child-Pugh score, and TNM staging independent predictors.
Journal ArticleDOI

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

TL;DR: Semiannual surveillance increases the detection rate of very early hepatocellular carcinomas and reduces the number of advanced tumors as compared to the annual program, which translates into a greater applicability of effective treatments and into a better prognosis.
Journal ArticleDOI

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study

TL;DR: The results indicate that liver cell dysplasia is a major risk factor for HCC, and it should be looked for carefully by pathologists in liver biopsy specimens to identify patients requiring more intensive observation.
Journal ArticleDOI

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development

TL;DR: Macronodules characterize a cirrhotic subpopulation with high risk of hepatocellular carcinoma; HGDN and LCC are strong predictors of malignant transformation; subjects with simultaneous presence of both these two conditions are at highest risk of cancer development.